Matches in Nanopublications for { <http://rdf.disgenet.org/resource/nanopub/NP258191.RANMVUi-vA_tDomPue6OQORfP8Q5LKL36FRf1URpnfJnY130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP258191.RANMVUi-vA_tDomPue6OQORfP8Q5LKL36FRf1URpnfJnY130_assertion type Assertion NP258191.RANMVUi-vA_tDomPue6OQORfP8Q5LKL36FRf1URpnfJnY130_head.
- NP258191.RANMVUi-vA_tDomPue6OQORfP8Q5LKL36FRf1URpnfJnY130_assertion description "[The Axl receptor tyrosine kinase (RTK) has been established as a strong candidate for targeted therapy of cancer.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP258191.RANMVUi-vA_tDomPue6OQORfP8Q5LKL36FRf1URpnfJnY130_provenance.
- NP258191.RANMVUi-vA_tDomPue6OQORfP8Q5LKL36FRf1URpnfJnY130_assertion evidence source_evidence_literature NP258191.RANMVUi-vA_tDomPue6OQORfP8Q5LKL36FRf1URpnfJnY130_provenance.
- NP258191.RANMVUi-vA_tDomPue6OQORfP8Q5LKL36FRf1URpnfJnY130_assertion SIO_000772 24862757 NP258191.RANMVUi-vA_tDomPue6OQORfP8Q5LKL36FRf1URpnfJnY130_provenance.
- NP258191.RANMVUi-vA_tDomPue6OQORfP8Q5LKL36FRf1URpnfJnY130_assertion wasDerivedFrom befree-20150227 NP258191.RANMVUi-vA_tDomPue6OQORfP8Q5LKL36FRf1URpnfJnY130_provenance.
- NP258191.RANMVUi-vA_tDomPue6OQORfP8Q5LKL36FRf1URpnfJnY130_assertion wasGeneratedBy ECO_0000203 NP258191.RANMVUi-vA_tDomPue6OQORfP8Q5LKL36FRf1URpnfJnY130_provenance.